Fonte: Current Analytical Chemistry. Unidade: FCF
Assuntos: ELETROFORESE CAPILAR DE ZONA, FORMAS FARMACÊUTICAS
ABNT
NAGASE, Fernanda Naomi Inagaki et al. Development and validation of a capillary zone electrophoresis method for the quantitative determination of atypical antipsychotic risperidone in pharmaceutical dosage forms. Current Analytical Chemistry, v. 10, n. 2, p. 205-215, 2014Tradução . . Disponível em: http://eurekaselect.com/111754. Acesso em: 16 nov. 2024.APA
Nagase, F. N. I., Asato, A. E., García, P. L., Galdos, A. A. G., Santoro, M. I. R. M., Kedor-Hackmann, E. R. M., & Aurora-Prado, M. S. (2014). Development and validation of a capillary zone electrophoresis method for the quantitative determination of atypical antipsychotic risperidone in pharmaceutical dosage forms. Current Analytical Chemistry, 10( 2), 205-215. Recuperado de http://eurekaselect.com/111754NLM
Nagase FNI, Asato AE, García PL, Galdos AAG, Santoro MIRM, Kedor-Hackmann ERM, Aurora-Prado MS. Development and validation of a capillary zone electrophoresis method for the quantitative determination of atypical antipsychotic risperidone in pharmaceutical dosage forms [Internet]. Current Analytical Chemistry. 2014 ; 10( 2): 205-215.[citado 2024 nov. 16 ] Available from: http://eurekaselect.com/111754Vancouver
Nagase FNI, Asato AE, García PL, Galdos AAG, Santoro MIRM, Kedor-Hackmann ERM, Aurora-Prado MS. Development and validation of a capillary zone electrophoresis method for the quantitative determination of atypical antipsychotic risperidone in pharmaceutical dosage forms [Internet]. Current Analytical Chemistry. 2014 ; 10( 2): 205-215.[citado 2024 nov. 16 ] Available from: http://eurekaselect.com/111754